Exploring the presence of DFG-funded publications in Naunyn-Schmiedeberg's Archives of Pharmacology
- PMID: 40343451
- DOI: 10.1007/s00210-025-04254-0
Exploring the presence of DFG-funded publications in Naunyn-Schmiedeberg's Archives of Pharmacology
Abstract
The primary objective of this study is to analyze the number of Deutsche Forschungsgemeinschaft (DFG)-sponsored papers published in Naunyn-Schmiedeberg's Archives of Pharmacology (NSAP), the oldest pharmacology journal in the world. This is the first systematic investigation of DFG-sponsored research in NSAP. Using the Scopus database, which provides comprehensive citation data from 1969 onward (for NSAP), the study identifies DFG-sponsored publications in the fields of pharmacology, toxicology, and pharmaceutics. The analysis includes only peer-reviewed articles and reviews, excluding other document types such as conference proceedings or editorials etc. The results show that, out of 453,047 total DFG-sponsored publications from 1969 to the present, only 3.05% (13,847) are in the specialized fields of pharmacology, toxicology, and pharmaceutics. This is relatively low compared to other research areas such as biochemistry, genetics, and molecular biology (24.69%), and physics and astronomy (23.37%). The study further analyzes the yearly publication dynamics of DFG-sponsored papers in NSAP, revealing a concerning trend: between 2015 and 2023, fewer than 10 DFG-sponsored papers were published in each of these years, with the lowest being 2 publications in 2022. These findings raise questions regarding the visibility and contribution of DFG-funded research in NSAP and suggest that strategies could be developed to enhance the presence of DFG-sponsored research in this historically significant journal. The study does not aim to interfere with funding policies but encourages a discussion on ways to improve publication outcomes for DFG-sponsored projects, particularly in well-established journals like NSAP. Collaboration between researchers, universities, and funding bodies may be key to promoting the visibility and impact of DFG-funded research in relevant academic journals.
Keywords: Deutsche forschungsgemeinschaft; Naunyn–Schmiedeberg’s Archives of Pharmacology; Pharmacology research; Publication analysis; Research funding; Scopus.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Germany in pharmacology publishing: 192 articles with 1367 citations in Naunyn-Schmiedeberg's Archives vs. 16,775 articles with 274,225 citations elsewhere.Naunyn Schmiedebergs Arch Pharmacol. 2025 May 1. doi: 10.1007/s00210-025-04224-6. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40310531
-
Authorship analysis of publications in Naunyn-Schmiedeberg's Archives of Pharmacology (1969-2024).Naunyn Schmiedebergs Arch Pharmacol. 2025 May 19. doi: 10.1007/s00210-025-04253-1. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40387930
-
Bibliometric analysis of Naunyn-Schmiedeberg's Archives of Pharmacology (1947-1974).Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):7141-7168. doi: 10.1007/s00210-024-03078-8. Epub 2024 Apr 23. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38652278 Free PMC article.
-
Where Are We with Deep Brain Stimulation? A Review of Scientific Publications and Ongoing Research.Stereotact Funct Neurosurg. 2022;100(3):184-197. doi: 10.1159/000521372. Epub 2022 Feb 1. Stereotact Funct Neurosurg. 2022. PMID: 35104819 Review.
-
The large part German medicine has played in the development of experimental pharmacology in Japan.Naunyn Schmiedebergs Arch Pharmacol. 2023 Jan;396(1):35-42. doi: 10.1007/s00210-022-02308-1. Epub 2022 Oct 25. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36282300 Review.
References
-
- Adams JD, Griliches Z (1998) Research productivity in a system of universities. Ann Écon Stat 49–50:127–162
-
- Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290(7):921–928. https://doi.org/10.1001/jama.290.7.921 - DOI - PubMed
-
- Arora A, Gambardella A (2005) The impact of NSF support for basic research in economics. Ann Écon Stat 79–80:91–117
-
- Arora A, David P, Gambardella A (1998) Reputation and competence in publicly funded science: estimating the effects on research group productivity. Ann Econ Stat 49–50:163–198
-
- Ayoubi C, Pezzoni M, Visentin F (2019) The important thing is not to win, it is to take part: what if scientists benefit from participating in research grant competitions? Res Policy 48:84–97 - DOI
LinkOut - more resources
Full Text Sources